Product Information

VARENICLINE 1 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3544 per EA under NDC 68462089456. Its NADAC has been published 162 times since Oct 11, 2023.

FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VARENICLINE 1 MG TABLET

varenicline tartrate
$0.3544per EA

Strength

1 mg/1

NDC

68462089456

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

VARENICLINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214255

FDA Approved

8/1/2023

TE Code

AB

On Market Since

8/22/2023

Pharmacological Classes

Cholinergic Agonists
Cholinergic Receptor Agonist
Partial Cholinergic Nicotinic Agonist
Partial Cholinergic Nicotinic Agonists

Price Statistics

The NADAC for VARENICLINE 1 MG TABLET has been published 162 times since Oct 11, 2023, and over the history we have for it it has declined 93.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3544 per EA
All-time high$5.4599 (Oct 11, 2023)
All-time low$0.3161 (Sep 23, 2026)
52-week high$0.4396
52-week low$0.3161
Median price$0.5541
Average price$1.0921
Largest weekly change-51.0% (Nov 20, 2024)
Weeks tracked162
Tracking sinceOct 11, 2023

Price History

1W

0.0%

1M

+12.1%

3M

-7.6%

6M

-13.8%

1Y

-23.1%

3Y

-92.2%

5Y

N/A

All

-93.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VARENICLINE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 1 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3544 per EA (NDC 68462089456), effective Nov 11, 2026.

How has the price of VARENICLINE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for VARENICLINE 1 MG TABLET has declined 93.5%. It has been tracked across 162 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for VARENICLINE 1 MG TABLET?

Since Oct 11, 2023, the NADAC for VARENICLINE 1 MG TABLET has ranged from a low of $0.3161 (Sep 23, 2026) to a high of $5.4599 (Oct 11, 2023), with a median of $0.5541 per EA.

Are there cheaper alternatives to VARENICLINE 1 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VARENICLINE 1 MG CONT MONTH BX, is $0.3503 per EA — about 1% below VARENICLINE 1 MG TABLET.

Who manufactures VARENICLINE 1 MG TABLET?

VARENICLINE 1 MG TABLET (NDC 68462089456) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.